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Alterations in metabolic signaling pathways allow tumors
to achieve balance between oxygen supply and consump-
tion via activation of several genes involved in adaptation
to low oxygen conditions (hypoxia). Hypoxia stimulates
glucose uptake, glycolysis and changes in mitochondrial
respiration in tumors as a direct result of increased HIF-1
transcriptional activity. HIF-1a stabilization induces the
expression of genes involved in cell survival, proliferation,
angiogenesis and glucose transport (GLUTs) and the sti-
mulation of genes involved in glycolytic energy produc-
tion. Elevated anaerobic metabolism results in increased
production of lactate as an alternate cellular energy source.
Recent studies suggested that increased levels of lactate in
tumors are associated with tumor progression, develop-
ment of metastases, radioresistance and decrease of patient
survival. Therefore, the ability to monitor products of
altered metabolism in tumors would provide valuable
information to improve cancer treatment.
We have developed a novel high-resolution imaging sys-
tem to assess the distribution of metabolites in tumors
such as lactate and ATP. Initial tests demonstrate the
capacity of this technique in providing quantitative mea-
surements of metabolites with high spatial resolution. This
technology offers several important advantages over other
techniques including ease of translation to the clinic,
microscopic spatial localization and quantitation of meta-
bolite concentration. Another advantage on the use of this
technique is the possibility of spatial co-registration of
metabolites with other tumors biomarkers. The main
focus of this approach is the development of novel tech-
nologies for imaging tumor metabolism. This will lead to a
better understanding of the role of tumor metabolism in
treatment outcome, leading to more rationale therapeutic
protocols.
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